Eli Lilly's latest clinical readout for dual GIP/GLP-1 agonist tirzepatide is a big one, with data suggesting the drug can reduce the risk of developing type 2 diabetes in overweight and obese adults ...
Illinois’ Brad Underwood is a man who knows what he wants. And his wish list generally consists of two must-haves: positional size and shooting – both of which the latest Illini commit has in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback